Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 29, 1997

View Archived Issues

DepoTech: Q3 1997 highlights

Penwest: Q4 and FY 1997 highlights

Kyowa Hakko: Annual Report 1997

Tripos: Q3 1997 highlights

Antitumor effects of Techniclone's LYM-2 reported

FDA clears generic estradiol product

Lilly and Chugai enter into combinatorial chemistry collaboration

Apligraf comparable to autograft for donor site wounds

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Biomeasure discloses protein farnesyltranserase inhibitors

Endothelin antagonists described by Bristol-Myers Squibb

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Effects of NO donor ITF-1129 on blood flow/hemodynamics during myocardial ischemia

Advisory committee recommends approval for Plavix

Banyu discloses protein farnesyltransferase inhibitors

New ACAT inhibitors discovered at Mitsubishi Chemical

Update on Sano product pipeline

Pravachol now available in Canada for preventing a first heart attack

Differin is equieffective but better tolerated than Retin A in patients with acne

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Hepatitis C-related technology available for licensing from NIH

Lyme disease diagnostic technology available for licensing

MuLV diagnostic kit available from NIH

FDA clears generic cimetidine

Gene therapy approach to preventing organ transplant complication explored

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...